| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9157883 | Atherosclerosis | 2005 | 7 Pages |
Abstract
These results suggest that the diverging impact of simvastatin and atorvastatin on plasma HDL-C levels in humans may be attributable, at least partly, to a greater production rate of apoA-I with simvastatin.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jean-François Mauger, Patrick Couture, Marie-Eve Paradis, Benoît Lamarche,